Lu Yu

976 total citations
48 papers, 685 citations indexed

About

Lu Yu is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Lu Yu has authored 48 papers receiving a total of 685 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 15 papers in Genetics and 15 papers in Oncology. Recurrent topics in Lu Yu's work include Chronic Myeloid Leukemia Treatments (19 papers), Chronic Lymphocytic Leukemia Research (14 papers) and Pancreatic and Hepatic Oncology Research (11 papers). Lu Yu is often cited by papers focused on Chronic Myeloid Leukemia Treatments (19 papers), Chronic Lymphocytic Leukemia Research (14 papers) and Pancreatic and Hepatic Oncology Research (11 papers). Lu Yu collaborates with scholars based in China, United Kingdom and Switzerland. Lu Yu's co-authors include Xianjun Yu, Chen Liu, Guopei Luo, Kaizhou Jin, Qian Jiang, Jiang Long, Quanxing Ni, Meng Guo, Cheng He and Jin Xu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer.

In The Last Decade

Lu Yu

42 papers receiving 676 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lu Yu China 16 383 158 143 131 124 48 685
Leonard Christopher Schmeel Germany 16 237 0.6× 130 0.8× 140 1.0× 66 0.5× 87 0.7× 67 816
Shuncong Wang China 16 349 0.9× 209 1.3× 143 1.0× 47 0.4× 98 0.8× 40 773
Laura Gardner United States 16 222 0.6× 179 1.1× 82 0.6× 47 0.4× 84 0.7× 42 702
Lucien Perey Switzerland 18 444 1.2× 321 2.0× 109 0.8× 116 0.9× 117 0.9× 43 878
Leon Hooftman United Kingdom 14 229 0.6× 302 1.9× 143 1.0× 126 1.0× 67 0.5× 35 1.2k
Seong Hyun Jeong South Korea 17 362 0.9× 216 1.4× 79 0.6× 75 0.6× 89 0.7× 67 761
Laura Finn United States 11 291 0.8× 209 1.3× 97 0.7× 131 1.0× 35 0.3× 39 931
Asima Mukhopadhyay India 17 641 1.7× 520 3.3× 72 0.5× 52 0.4× 143 1.2× 59 1.3k
Mark Cornfeld United States 11 497 1.3× 294 1.9× 36 0.3× 127 1.0× 112 0.9× 33 838
Yabing Cao China 15 350 0.9× 191 1.2× 189 1.3× 39 0.3× 132 1.1× 52 811

Countries citing papers authored by Lu Yu

Since Specialization
Citations

This map shows the geographic impact of Lu Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Yu more than expected).

Fields of papers citing papers by Lu Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lu Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Yu. The network helps show where Lu Yu may publish in the future.

Co-authorship network of co-authors of Lu Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Lu Yu. A scholar is included among the top collaborators of Lu Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lu Yu. Lu Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Li, Xin Sun, Qin Zhu, et al.. (2025). CD205-targeted bispecific nanobody enhances antigen presentation and immune responses in FMDV. SHILAP Revista de lepidopterología. 4(3). 100131–100131.
2.
Yu, Lu, Weiming Li, Na Xu, et al.. (2024). Patient‐reported outcomes in adults with tyrosine kinase inhibitor‐resistant chronic myeloid leukemia receiving olverembatinib therapy. Cancer. 131(1). e35652–e35652. 1 indexed citations
3.
Yu, Lu, et al.. (2024). Mitochondrial-derived peptides, HNG and SHLP3, protect cochlear hair cells against gentamicin. Cell Death Discovery. 10(1). 445–445. 1 indexed citations
4.
Wang, Yang, et al.. (2023). Future trajectory of SARS-CoV-2: Constant spillover back and forth between humans and animals. Virus Research. 328. 199075–199075. 15 indexed citations
5.
Yu, Lu, et al.. (2023). Exogenous humanin and MOTS-c function as protective agents against gentamicin-induced hair cell damage. Biochemical and Biophysical Research Communications. 678. 115–121. 2 indexed citations
6.
7.
8.
Yu, Lu, Robert Peter Gale, Ya‐Zhen Qin, et al.. (2021). Impact of socio-demographic co-variates on prognosis, tyrosine kinase-inhibitor use and outcomes in persons with newly-diagnosed chronic myeloid leukaemia. Journal of Cancer Research and Clinical Oncology. 148(2). 449–459. 2 indexed citations
9.
10.
Jiang, Qian, Lu Yu, & Robert Peter Gale. (2018). Patients’ and hematologists’ concerns regarding tyrosine kinase-inhibitor therapy in chronic myeloid leukemia. Journal of Cancer Research and Clinical Oncology. 144(4). 735–741. 14 indexed citations
11.
Jiang, Qian, Lu Yu, Ya‐Zhen Qin, Yue‐Yun Lai, & Xiao‐Jun Huang. (2017). Comparison of the Outcome between Newly Diagnosed Patients in the Accelerated Phase and Chronic Phase with Chronic Myeloid Leukemia Treated with Frontline Tyrosine Kinase Inhibitors. Blood. 130. 2876–2876. 1 indexed citations
12.
Jiang, Qian, Haibo Wang, Lu Yu, & Robert Peter Gale. (2017). Higher out-of-pocket expenses for tyrosine kinase-inhibitor therapy is associated with worse health-related quality-of-life in persons with chronic myeloid leukemia. Journal of Cancer Research and Clinical Oncology. 143(12). 2619–2630. 23 indexed citations
13.
Luo, Guopei, Chen Liu, Cheng He, et al.. (2017). Neutrophil-lymphocyte ratio predicts survival in pancreatic neuroendocrine tumors. Oncology Letters. 13(4). 2454–2458. 32 indexed citations
14.
Jiang, Qian, et al.. (2017). Variables associated with patient-reported outcomes in persons with chronic myeloid leukemia receiving tyrosine kinase-inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 143(6). 1013–1022. 14 indexed citations
15.
Luo, Guopei, Kaizhou Jin, Cheng He, et al.. (2017). Revised nodal stage for pancreatic neuroendocrine tumors. Pancreatology. 17(4). 599–604. 9 indexed citations
16.
Luo, Guopei, Meng Guo, Kaizhou Jin, et al.. (2016). Optimize CA19-9 in detecting pancreatic cancer by Lewis and Secretor genotyping. Pancreatology. 16(6). 1057–1062. 48 indexed citations
17.
Luo, Guopei, Kaizhou Jin, Meng Guo, et al.. (2016). Patients with normal-range CA19-9 levels represent a distinct subgroup of pancreatic cancer patients. Oncology Letters. 13(2). 881–886. 17 indexed citations
18.
Luo, Guopei, Chen Liu, Meng Guo, et al.. (2016). CA19-9-Low&Lewis (+) pancreatic cancer: A unique subtype. Cancer Letters. 385. 46–50. 20 indexed citations
19.
Luo, Guopei, Chen Liu, Meng Guo, et al.. (2016). Potential Biomarkers in Lewis Negative Patients With Pancreatic Cancer. Annals of Surgery. 265(4). 800–805. 128 indexed citations
20.
Yu, Lu, Cheng He, Si Shi, et al.. (2014). Abnormal distribution of peripheral lymphocyte subsets induced by PDAC modulates overall survival. Pancreatology. 14(4). 295–301. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leonard Christopher Schmeel Breakdown of academic impact, for papers by Shuncong Wang Breakdown of academic impact, for papers by Laura Gardner Breakdown of academic impact, for papers by Lucien Perey Breakdown of academic impact, for papers by Leon Hooftman Breakdown of academic impact, for papers by Seong Hyun Jeong Breakdown of academic impact, for papers by Laura Finn Breakdown of academic impact, for papers by Asima Mukhopadhyay Breakdown of academic impact, for papers by Mark Cornfeld Breakdown of academic impact, for papers by Yabing Cao
Rankless by CCL
2026